Рет қаралды 487
Learn more about the latest guidelines and recommendations to initiate biologic therapy and control moderate-to-severe asthma symptoms during this educational program. An expert panel discussed:
- The role of type 2 inflammation in asthma pathophysiology
- How to identify patients with uncontrolled moderate-to-severe asthma that could benefit from the use of a biologic
- Current data on the efficacy and safety of biologics used for patients with moderate-to-severe asthma and comorbid inflammatory conditions
To learn more about type 2 inflammation, visit: aafa.org/progr...
To learn more about asthma treatment options, visit: aafa.org/asthm...